DE60123583D1 - Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome - Google Patents

Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome

Info

Publication number
DE60123583D1
DE60123583D1 DE60123583T DE60123583T DE60123583D1 DE 60123583 D1 DE60123583 D1 DE 60123583D1 DE 60123583 T DE60123583 T DE 60123583T DE 60123583 T DE60123583 T DE 60123583T DE 60123583 D1 DE60123583 D1 DE 60123583D1
Authority
DE
Germany
Prior art keywords
sugar
lipid
liposome
rehydratisation
dehydratisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60123583T
Other languages
English (en)
Other versions
DE60123583T2 (de
Inventor
Brahim Zadi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipoxen Technologies Ltd
Original Assignee
Lipoxen Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipoxen Technologies Ltd filed Critical Lipoxen Technologies Ltd
Application granted granted Critical
Publication of DE60123583D1 publication Critical patent/DE60123583D1/de
Publication of DE60123583T2 publication Critical patent/DE60123583T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
DE60123583T 2000-02-04 2001-01-31 Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome Expired - Lifetime DE60123583T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00300904 2000-02-04
EP00300904 2000-02-04
PCT/GB2001/000391 WO2001056548A2 (en) 2000-02-04 2001-01-31 Liposomes composition produced by a dehydration-rehydration process

Publications (2)

Publication Number Publication Date
DE60123583D1 true DE60123583D1 (de) 2006-11-16
DE60123583T2 DE60123583T2 (de) 2007-08-09

Family

ID=8172682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123583T Expired - Lifetime DE60123583T2 (de) 2000-02-04 2001-01-31 Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome

Country Status (8)

Country Link
US (1) US7025988B2 (de)
EP (1) EP1259225B1 (de)
JP (1) JP4786105B2 (de)
AT (1) ATE341310T1 (de)
AU (1) AU2869901A (de)
DE (1) DE60123583T2 (de)
ES (1) ES2272496T3 (de)
WO (1) WO2001056548A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502653A (ja) * 2001-08-20 2005-01-27 トランセーヴ・インコーポレーテッド 肺ガンの治療方法
PT1509256E (pt) 2002-05-24 2009-10-15 Angiotech Int Ag Composições e métodos de revestimento de implantes médicos
CA2491216C (en) 2002-06-26 2012-01-03 Medigene Oncology Gmbh Method of producing a cationic liposomal preparation comprising a lipophilic compound
EP1519745B1 (de) 2002-07-05 2006-12-20 Lipoxen Technologies Limited Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
KR20050038011A (ko) * 2002-08-02 2005-04-25 트랜세이브, 인코포레이티드 백금 응집체 및 이의 제조 방법
CN100518831C (zh) * 2002-08-15 2009-07-29 刘云清 固体纳米药物及其制备方法
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
BRPI0407415A (pt) * 2003-02-11 2006-01-10 Neopharm Inc Método de fabricar um preparado lipossÈmico
JP2007522085A (ja) * 2003-06-27 2007-08-09 スミスクライン・ビーチャム・コーポレイション 安定化されたトポテカンリポソーム組成物および方法
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
EP1729786A4 (de) * 2004-03-18 2008-03-26 Transave Inc Verabreichung von cisplatin durch inhalation
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
KR101462825B1 (ko) 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
WO2005112957A1 (en) * 2004-05-21 2005-12-01 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
US20050281799A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US7766938B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Pleural effusion treatment device, method and material
KR20070089693A (ko) * 2004-11-08 2007-08-31 트랜세이브, 인코포레이티드 지질-기재 플래티넘 화합물 제형을 복막내 투여하여 암을치료하는 방법
JP5303269B2 (ja) 2005-06-06 2013-10-02 学校法人早稲田大学 骨髄指向性薬物送達物質およびその用途
TWI291237B (en) * 2005-10-07 2007-12-11 Integrated Digital Technologie Photo detector array
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056264A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
PL1962805T3 (pl) 2005-12-08 2017-01-31 Insmed Incorporated Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
ES2668554T3 (es) * 2006-04-06 2018-05-18 Insmed Incorporated Métodos para la encapsulación liposomal inducida por coacervación y sus formulaciones
WO2008036763A2 (en) * 2006-09-20 2008-03-27 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
CA2734284C (en) * 2008-11-20 2014-01-21 Techno Guard Co., Ltd. Pyrazolone derivative formulations
US8591942B2 (en) * 2009-09-23 2013-11-26 Indu JAVERI Methods for the preparation of liposomes comprising docetaxel
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2394640A1 (de) * 2010-05-21 2011-12-14 MediGene AG Verbesserte liposomale Formulierungen von lipophilen Verbindungen
JP6402097B2 (ja) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
US9717724B2 (en) 2012-06-13 2017-08-01 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
AU2013202947B2 (en) 2012-06-13 2016-06-02 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
EP2682106A1 (de) 2012-07-03 2014-01-08 Phares Pharmaceutical Research N.V. Verfahren zum Auflösen biologisch aktiver Verbindungen
WO2014034669A1 (ja) * 2012-08-28 2014-03-06 国立大学法人北海道大学 非極性溶媒に分散性を有する細菌菌体成分を内封する脂質膜構造体およびその製造方法
JP2015530387A (ja) 2012-09-04 2015-10-15 エライゾン ファーマシューティカルズ， エルエルシー 脂質複合体化シスプラチンによる肺癌の再発防止
ES2743039T3 (es) 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
US10238675B2 (en) 2014-05-15 2019-03-26 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
US11318131B2 (en) 2015-05-18 2022-05-03 Ipsen Biopharm Ltd. Nanoliposomal irinotecan for use in treating small cell lung cancer
RU2760185C2 (ru) 2015-08-20 2021-11-22 Ипсен Биофарм Лтд. Комбинированная терапия с применением липосомального иринотекана и ингибитора parp для лечения рака
WO2017034957A1 (en) 2015-08-21 2017-03-02 Merrimack Pharmaceuticals, Inc. Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
EP3362049A1 (de) 2015-10-16 2018-08-22 Ipsen Biopharm Ltd. Stabilisierung von pharmazeutischen camptothecinzusammensetzungen
CN106924195B (zh) * 2015-12-31 2020-11-13 南京绿叶制药有限公司 一种注射用紫杉醇脂质体组合物的冻干工艺
MY198105A (en) * 2016-01-07 2023-08-02 Univ Western Health Sciences Formulations for treating bladder cancer
AU2017351900B2 (en) * 2016-10-31 2020-11-26 Eyegene Inc. Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same
SG10201912338RA (en) 2016-11-02 2020-02-27 Ipsen Biopharm Ltd Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin)
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4885172A (en) * 1985-06-26 1989-12-05 The Liposome Company, Inc. Composition for targeting, storing and loading of liposomes
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
FR2593394A1 (fr) * 1986-01-30 1987-07-31 Ire Celltarg Sa Procede de preparation de liposomes contenant une subtance active lipophile, notamment de l'amphotericine, liposomes et nouveau medicament obtenus
AU6833994A (en) * 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4432378A1 (de) 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen
EP0792143B1 (de) * 1994-11-18 2002-09-04 Aphios Corporation Verfahren zur Herstellung von Liposomen, die hydrophobische Artzneistoffe enthalten
GB9813100D0 (en) 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane

Also Published As

Publication number Publication date
DE60123583T2 (de) 2007-08-09
AU2869901A (en) 2001-08-14
JP4786105B2 (ja) 2011-10-05
ATE341310T1 (de) 2006-10-15
ES2272496T3 (es) 2007-05-01
US7025988B2 (en) 2006-04-11
JP2003521508A (ja) 2003-07-15
US20030138481A1 (en) 2003-07-24
WO2001056548A2 (en) 2001-08-09
EP1259225B1 (de) 2006-10-04
WO2001056548A3 (en) 2002-03-21
EP1259225A2 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
DE60123583D1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
TW359616B (en) A parenterally administered pharmaceutical composition for lipophilic, poorly soluble active compounds, in the form of liposomes with phospholipid membranes
EP0277776A3 (de) Liposome mit harten Kernen
AU8141891A (en) Unilamellar vesicles
NZ334561A (en) Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents
CA2227761A1 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
DK0831779T3 (da) Fremgangsmåde til fremstilling af liposompræparat
WO1999016426A3 (en) Multilamellar coalescence vesicles (mlcv) containing biologically active compounds
KR880001284A (ko) 단일 이중층 리포좀의 제조방법
DK0560138T3 (da) Liposomale præparater af virksomt stof og fremgangsmåde til deres fremstilling
EP0198765A3 (de) Herstellung von Liposomen
CA2488124A1 (en) Vitamin a liposomes and the method of its preparation
HUT62457A (en) Process for producing aqueous liposomal suspensions comprising an active ingredient
EA200501252A1 (ru) Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
CA2177696A1 (en) Lipid vesicles containing avocado oil unsaponifiables
DE59914774D1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
WO2003026617A8 (de) (ester)-lysolecithine in liposomen
UENO et al. Interaction of liposomes with detergents
IT1269569B (it) Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
Ravivarapu et al. Formulation and characterization of azidothymidine-loaded liposomes
UA6700C2 (uk) Спосіб одержання липосомальної форми протипухлинного антибіотика
Matveev et al. Preparation of liposomes from yeast phospholipids
TH20333B (th) สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้
TH20333A (th) สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้

Legal Events

Date Code Title Description
8364 No opposition during term of opposition